AN EVALUATION OF THE COSTS ASSOCIATED WITH ACUTE MI TREATMENT IN AND OUT OF HOSPITALS IN GREECE

Author(s)

Maniadakis N1, Fragoulakis B2, Liapis M3, Hatzikou M4 , 1University of Patras, Patras, Greece, Greece; 2University Hospital Patras, Patras, Greece, Greece; 3Boehringer Ingelheim, Athens, Greece, Greece; 4Boehringer Ingelheim, Athens, Greece

OBJECTIVES: To evaluate the inpatient and outpatient maintenance costs associated with treatment for acute myocardial infarction in the Greek NHS. METHODS: A database from a large NHS University Hospital was employed and analyzed. Resource consumption data were combined with 2003 price data to compute overall treatment costs. Inpatient costs of an uncomplicated AMI comprise all costs associated with treating an event in-hospital and these include the costs of wards, PTCAs, medications, cardiac ICU, etc. The marginal costs of having one of many types of events, such as strokes, re-infarction, etc, are also computed. The outpatient maintenance costs of patients include medication taken after the AMI for certain period or life-time, visits to professionals and rehabilitation in cases of events such as strokes. RESULTS: The costs of initial inpatient medication given is between €790 and €1000. The average cost of hospitalization is about €8.474 and the additional cost per event is as follows: stroke-€1300, bleeding-€90, reinfraction-€1125, recurrent ischemia:0, CHF-€561, hypotention: 0, cardiogenic chock-€1.730, electromechanical dissociation-€121, tamponate or cardiac rapture-€279, second degree atrioventicular block-€961, third degree atrioventicular block: €1.521, artial fibrillation: €100, asystole: €121, acute mitral requirgitation-€1.415, septal defect: €415, anaphylaxis:€300, pulmonary embolism: €2.050, arrythmias:€100, hypotention: €0, pericarditis-€100. The cost of rehabilitation and maintenance is on average €915 in the first year plus €4.5 per day after discharge and during lifetime thereafter. Severe stroke is associated with an extra of €1.000 in the first year. CONCLUSION: AMI is an expensive to treat event. The cost of initial medication given is low in comparison with the total treatment cost within the hospital and after discharge. The associated events are also very expensive to treat and multiply total cost. Any reduction therefore in MI's, given the high prevalence, will save the NHS and the taxpayer a lot of money.

Conference/Value in Health Info

2003-11, ISPOR Europe 2003, Barcelona, Spain

Value in Health, Vol. 6, No. 6 (November/December 2003)

Code

PCV43

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×